💊 Is This Pfizer ($PFE) Breakout Built to Last?
💡Daily Trade Idea – Friday Oct. 3, 2025 – $PFE Trade Setup and Technical Breakdown
Good morning, traders and investors — I’m taking it in a slightly different direction today. I’m breaking down Pfizer (PFE), and full disclosure, this is a stock that I’ve already been building a long-term position in, and with the news that just hit this week, I’m looking to add more. Pfizer pays a fat dividend — over 6% right now — which makes it the kind of stock I actually want to own. The way I’m structuring this, I’ll be walking you through a short-term setup, a longer-term investor approach, and an options strategy to either collect premium or grab shares cheaper.
📰 The Story
Pfizer caught a big headline this week:
They negotiated a three-year reprieve on drug-import tariffs with the Trump administration.
In return, they agreed to offer discounts on some Medicaid drugs and boost U.S. manufacturing.
The White House also announced a “TrumpRx” platform that gives Americans bigger discounts on certain Pfizer medications.
The market loved it — shares ripped higher in a relief rally. Now, most traders are chasing the move. Me? I was already in this name. This is just giving me a better excuse to add more.
Pfizer still has work to do managing its pipeline, M&A, and upcoming expirations, but the dividend, the cost-cutting story, and now this tariff break all support the idea of building a position here.
📈 Technical Breakdown
Price Action: PFE closed Thursday at $27.08 after a massive surge off the lows earlier in the week. Volume spiked hard, confirming buyers are stepping in.
Moving Averages: Price is now trading above the 10-day ($24.73), 50-day ($24.63), and 200-day ($24.82) moving averages — that’s full alignment to the upside.
Candlesticks: Strong bullish candles with conviction, though after this kind of move, I wouldn’t be shocked to see a pause or slight pullback.
Trend: Short-term trend has flipped bullish, momentum is on Pfizer’s side.
📊 Indicators
RSI: 72 → That’s technically “overbought.” It doesn’t mean sell, but it does tell me a breather could be coming.
MACD: Just crossed positive with strong upside momentum. That supports the bullish case, but also warns of potential short-term exhaustion.
